Top news of the week: 06.10.2020.

#BioTech #pharma #NYC #lifesciences #COVID19 #NBTintheNews

Healthcare

On Oct 2, 2020
@Dominic_Tyer shared
Life science leaders sign new ‘Biotech Social Pact’ for Europe https://t.co/4qVrtINL9E #pharma #biotech https://t.co/qhyk469FdP
Open

Life science leaders sign new ‘Biotech Social Pact’ for Europe

Life science leaders sign new ‘Biotech Social Pact’ for Europe

The signatories of a new Biotech Social Pact with Europe and patients explain why healthcare calls for a new social contract, not a pharmaceutical strategy

On Oct 5, 2020
@BiotechSweden shared
Bone Therapeutics :, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia #BioTech via https://t.co/2sI0UxJbpn https://t.co/WgRG9pSDg4
Open

Bone Therapeutics :, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia

Bone Therapeutics :, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia

Regulated Information Bone Therapeutics grants exclusive license to Link Health and Pregene for the development and commercialization of ALLOB in Greater China and a number of other ...

On Oct 3, 2020
@BiotechSweden shared
2020 Biotech Funding: The US, Europe and Asia #BioTech via https://t.co/2sI0UxJbpn https://t.co/C08FbhnDIl
Open

Biotech Funding: The Tale of Three Regions

Biotech Funding: The Tale of Three Regions

Explore each of the three biggest regional funding scenes that make up the global Biotech landscape: the US, Europe and Asia.

On Oct 5, 2020
@BiotechSweden shared
RT @demy_sara: Check out my op-Ed piece in @ContractPharma https://t.co/s0t6hb61y5 @demycolton #NYC #lifesciences #biotech
Open

New York City is Not Dead, Our Life Sciences Sector is Thriving

New York City is Not Dead, Our Life Sciences Sector is Thriving

Amid the COVID-19 pandemic, life sciences is booming in NYC!

On Sep 30, 2020
@BiotechSweden shared
Regeneron's COVID-19 antibody cocktail curbs virus, speeds recovery in early data #BioTech via https://t.co/2sI0UxJbpn https://t.co/c8k1KLuwz4
Open

Regeneron’s COVID-19 antibody cocktail curbs virus, speeds recovery in early data

Regeneron’s COVID-19 antibody cocktail curbs virus, speeds recovery in early data

The first data are in for Regeneron’s COVID-19 antibody cocktail—and they’re encouraging. The top dose of the treatment lowered virus levels and relieved symptoms more quickly than placebo ...

On Oct 3, 2020
@CR_UK shared
🧒🏿 Is cancer different in children? 💻 Cancer: the next tech boom sector? 💊 Promising prostate cancer treatment results All this and more in our weekly news digest! https://t.co/BLohoq1ELk https://t.co/pDlGZNia1B
Open

News digest – HPV vaccine, 1 million breast screenings missed and prostate cancer treatment

News digest – HPV vaccine, 1 million breast screenings missed and prostate cancer treatment

Results from a new drug trial have found “one of the most promising breakthroughs for patients with this type of breast cancer in the last 20 years.'

On Oct 2, 2020
@NatureBiotech shared
This biologist helped trace SARS to bats. Now, he's working to uncover the origins of #COVID19 #NBTintheNews via @ScienceMagazine https://t.co/TPPb50weaG
Open

This biologist helped trace SARS to bats. Now, he's working to uncover the origins of COVID-19

This biologist helped trace SARS to bats. Now, he's working to uncover the origins of COVID-19

Linfa Wang's innovative new assay could help reveal when and where the virus spilled over to humans

On Oct 1, 2020
@BiotechSweden shared
RT @Bigboardalerts2: $NBIO Nascent #Biotech Continues to Reduce Liabilities by Over $2.0 Million Dollars https://t.co/TlKwn22Uha
Open

Nascent Biotech Continues to Reduce Liabilities by Over $2.0 Million Dollars

Nascent Biotech Continues to Reduce Liabilities by Over $2.0 Million Dollars

SAN DIEGO, CA / ACCESSWIRE / October 1, 2020 / Nascent Biotech, Inc.